Disease oriented treatment of metastatic colorectal cancer (CRC) with dose-dense 5-FU/Folinic acid (FU/FA) combination chemotherapy

被引：0
|
作者：
Loeffler, TM [1 ]
Droege, C [1 ]
Lenfers, BHM [1 ]
Hausamen, TU [1 ]
机构：
[1] Stadt Kliniken Dortmund, Dept Med, Dortmund, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80661-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
228
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [41] DTIC + MMC IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER AFTER FAILURE WITH HIGH-DOSE FOLINIC ACID PLUS 5-FU
    BARONE, C
    GARUFI, C
    ASTONE, A
    GRIECO, A
    BARONI, R
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1987, 6 (01) : 63 - 65
  • [42] FIRST LINE CHEMOTHERAPY (FLC) USING IRINOTECAN, 5-FLUOROURACIL (5-FU) AND FOLINIC ACID (FA) (FOLFIRI) COMBINED WITH BEVACIZUMAB IN MEATASTATIC COLORECTAL CANCER (MCRC)
    Gluzman, A.
    Fridman, J.
    Lazarev, I
    Walfish, S.
    Ariad, S.
    Lavrenkov, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 62 - 62
  • [43] 5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer
    Taïeb, J
    Lecomte, T
    Ezenfis, J
    Artru, P
    Mitry, E
    Boige, V
    Clavero-Fabri, MC
    Vaillant, N
    Rougier, P
    Ducreux, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (6-7): : 605 - 609
  • [44] Building on the foundation of 5-FU to treat metastatic colorectal cancer
    Eng, Cathy
    ONCOLOGY-NEW YORK, 2008, 22 (04): : 462 - +
  • [45] TREATMENT OF METASTATIC COLORECTAL-CARCINOMA WITH CISPLATIN AND 5-FU
    SHEPARD, KV
    FAINTUCH, J
    BITRAN, JD
    SWEET, DL
    ROBIN, E
    LEVIN, B
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 123 - 124
  • [46] FOLINIC ACID (FA) PLUS 5-FLUOROURACIL (FU) IN PROGRESSIVE ADVANCED COLORECTAL-CANCER
    WILKE, H
    SCHMOLL, HJ
    SCHOBER, C
    STAHL, M
    PREUSSER, P
    FREUND, M
    POLIWODA, H
    BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (06) : 373 - 380
  • [47] Irinotecan/5-FU/FA (I-FU) or 5-FU/FA (FU) first-line therapy in older and younger patients with metastatic colorectal cancer: Combined analysis of 2,691 patients in randomized controlled trials
    Folprecht, G.
    Seymour, M. T.
    Saltz, L.
    Douillard, J. Y.
    Stephens, R. J.
    Van Cutsem, E.
    Rougier, P.
    Maughan, T. S.
    Koehne, C. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] 5-Fluorouracil (5-FU) plus folinic acid (FA) for patients with advanced colorectal cancer (ACRC) treated outside clinical trials
    Segura, A
    Aparicio, J
    Garcera, S
    Reynes, G
    Montalar, J
    Santaballa, A
    Yuste, A
    Herranz, C
    ANNALS OF ONCOLOGY, 1998, 9 : 45 - 45
  • [49] COMBINATION CHEMOTHERAPY OF CISPLATIN AND 5-FU IN ADVANCED COLORECTAL-CARCINOMA
    DY, C
    GIL, A
    ALGARRA, SM
    APARICIO, LA
    CALVO, F
    HERRANZ, P
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 465 - 468
  • [50] Long-term follow-up of colorectal cancer (CRC) patients treated with neoadjuvant chemotherapy with irinotecan and fluorouracil plus folinic acid (5-FU/FA) for unresectable liver metastases.
    Pozzo, C.
    Basso, M.
    Quirino, M.
    Schinzari, G.
    Astone, A.
    Trigila, N.
    D'Argento, E.
    Sponziello, F.
    Cassano, A.
    Barone, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 164S - 164S
12345